Developing new light-responsive materials for therapy
Efficient red-to-NIR photo-uncaging and applications in therapy
This study is exploring new materials that can safely use special light to help deliver medications and treat conditions like cancer more effectively, making treatments less invasive and more precise for patients.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New Jersey Institute of Technology NIH-funded |
| Lab location | 1 site (Newark, United States) |
| Project ID | NIH-10794730 on NIH RePORTER |
What this research studies
This research focuses on creating innovative materials that respond to red-to-near-infrared light, which can penetrate tissues more effectively and cause less damage than traditional light sources. By utilizing advanced organic compounds, the project aims to enhance drug delivery systems, activate gene therapy, and modulate neurons through precise light control. Patients may benefit from improved therapies that are less invasive and more targeted, potentially leading to better outcomes in cancer treatment and other conditions. The approach involves synthesizing new chemical compounds and testing their effectiveness in various biological applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing treatment for cancers or conditions that could benefit from advanced drug delivery and gene therapy techniques.
Not a fit: Patients with conditions that do not involve the need for targeted drug delivery or light-responsive therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less harmful therapies for conditions like cancer.
How similar studies have performed: Other research has shown promise in using light-responsive materials for therapeutic applications, indicating a potential for success in this novel approach.
Where this research is happening
Newark, United States
- New Jersey Institute of Technology — Newark, United States (Active)
Researchers
- Principal investigator: Zhang, Yuanwei — New Jersey Institute of Technology
- Study coordinator: Zhang, Yuanwei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.